These are top 10 stocks traded on the Robinhood UK platform in July
On Wednesday, Raymond (NSE:RYMD) James reaffirmed its positive stance on CME Group (NASDAQ:CME), maintaining an Outperform rating and a $287.00 price target. The firm’s analysis indicates CME Group’s comprehensive risk management offerings are well-suited for the current volatile macroeconomic and geopolitical climate, as evidenced by strong recent trading volumes. According to InvestingPro data, CME is trading near its 52-week high of $267.91, with 12 analysts recently revising their earnings estimates upward for the upcoming period.
CME Group’s rate futures volumes have been performing better than expected, particularly Treasury futures, which have shown considerable strength. Additionally, the company’s energy futures business has been providing a boost, marking a reversal after several years of declines. Analysts at Raymond James now consider this uptrend in energy futures to be sustainable. The company’s strong performance is reflected in its impressive 9.9% revenue growth and robust market capitalization of $94.78 billion.
The firm believes that CME Group’s valuation multiple has room to grow, as concerns about the competitive environment and the effects of Federal Reserve rate cuts are diminishing. The assessment suggests that the current risk/reward profile for CME Group is appealing to investors, though InvestingPro analysis indicates the stock is currently trading slightly above its Fair Value.
CME Group, known for its diverse risk management products, has been able to capitalize on the increased market volatility, which has, in turn, driven trading volumes higher. This performance aligns with the company’s historical resilience in the face of market fluctuations.
The analyst’s outlook for CME Group remains robust, with the anticipation that the company will continue to benefit from the current market conditions. The reiterated Outperform rating reflects confidence in the firm’s future performance as it approaches the release of its first-quarter results for 2025.
In other recent news, CME Group Inc. reported a record-breaking average daily volume of 29.8 million contracts in the first quarter of 2025, showcasing significant growth across various asset classes, including interest rates, equity indexes, and cryptocurrencies. Additionally, CME Group has launched new Solana futures contracts, expanding its cryptocurrency offerings with both micro-sized and larger-sized options, reflecting a growing institutional interest in digital assets. The company also plans to introduce Bloomberg Commodity Subindex futures across seven key sectors, providing investors with new opportunities to manage sector-specific risks.
Meanwhile, Erste Group has initiated coverage on CME Group shares with a Buy rating, highlighting the company’s broad range of risk management tools and innovative product offerings. The analysts suggest that CME Group’s sales and earnings forecasts may be underestimated, indicating potential positive earnings surprises. Furthermore, Moody’s Ratings upgraded the long-term corporate family rating of CME Media Enterprises B.V. from B1 to Ba3, citing reduced leverage and solid operating performance. This upgrade reflects CME’s improved financial metrics and strategic focus on revenue diversification.
These developments underscore CME Group’s ongoing efforts to innovate and expand its product portfolio, catering to the evolving needs of market participants.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.